| Biomarker | Variant | ESCAT | Evidence | Clinical significance | Drugs | Sources |
|---|---|---|---|---|---|---|
| No clinically actionable variants matched in this profile. | ||||||
| Specialist | skill_id | Version | Last reviewed | Sign-offs | Domain |
|---|---|---|---|---|---|
| Cellular therapy specialist (CAR-T) | cellular_therapy_specialist | v0.1.0 | 2026-04-25 | 0 | cellular_therapy |
| Clinical pharmacist | clinical_pharmacist | v0.1.0 | 2026-04-25 | 0 | clinical_pharmacy |
| Hematologist / oncohematologist | hematologist | v0.1.0 | 2026-04-25 | 0 | hematology_oncology |
| Hematopathologist (lymphoma / leukemia / myeloma) | hematopathologist | v0.1.0 | 2026-04-25 | 0 | hematopathology |
| Infectious disease / hepatology | infectious_disease_hepatology | v0.1.0 | 2026-04-25 | 0 | infectious_diseases |
| Medical oncologist (solid-tumor chemotherapist) | medical_oncologist | v0.1.0 | 2026-04-25 | 0 | solid_oncology |
| Molecular geneticist / molecular oncologist | molecular_geneticist | v0.1.0 | 2026-04-25 | 0 | molecular_oncology |
| Palliative care | palliative_care | v0.1.0 | 2026-04-25 | 0 | palliative_care |
| Pathologist (general) | pathologist | v0.1.0 | 2026-04-25 | 0 | pathology |
| Primary care / family physician | primary_care | v0.1.0 | 2026-04-25 | 0 | primary_care |
| Psycho-oncologist | psychologist | v0.1.0 | 2026-04-25 | 0 | psychosocial |
| Radiation oncologist | radiation_oncologist | v0.1.0 | 2026-04-25 | 0 | radiation_oncology |
| Radiologist | radiologist | v0.1.0 | 2026-04-25 | 0 | diagnostic_imaging |
| Social worker / case manager | social_worker_case_manager | v0.1.0 | 2026-04-25 | 0 | psychosocial |
| Surgical oncologist | surgical_oncologist | v0.1.0 | 2026-04-25 | 0 | surgical_oncology |
| Transplant specialist (BMT) | transplant_specialist | v0.1.0 | 2026-04-25 | 0 | cellular_therapy |
| NCT | Title | Phase | Status | Sponsor | UA | Signals | Eligibility (excerpt) |
|---|---|---|---|---|---|---|---|
| NCT06923826 | Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC) | PHASE2 | RECRUITING | National University Hospital, Singapore | — | Small N (<50) Surrogate endpoint only Single country | |
| NCT06047236 | Immune Biomarker Study for Salivary Gland Carcinoma | N/A | RECRUITING | University of Erlangen-Nürnberg Medical School | — | Surrogate endpoint only Single country | |
| NCT04870762 | Customized 3D Printed Oral Stents During Head and Neck Radiotherapy | PHASE2 | RECRUITING | M.D. Anderson Cancer Center | — | Single country | |
| NCT04214366 | Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation | PHASE2 | RECRUITING | Heidelberg University | — | Single country | |
| NCT07686575 | Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma | N/A | RECRUITING | Zhujiang Hospital | — | Small N (<50) Surrogate endpoint only Single country | |
| NCT07072143 | An International Study on Pediatric Patients With Rare Tumors. | N/A | RECRUITING | Azienda Ospedaliera di Padova | — | Single country | |
| NCT07507578 | A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma | N/A | RECRUITING | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | — | Single country | |
| NCT00898638 | Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants | N/A | RECRUITING | Vanderbilt University Medical Center | — | Single country | |
| NCT06805617 | A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers | PHASE2 | RECRUITING | Glenn J. Hanna | — | Small N (<50) Surrogate endpoint only Single country | |
| NCT05483374 | The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers | N/A | RECRUITING | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | — | — |
Verify recruitment status directly with the trial site. ctgov data can lag behind current UA-site status.
| Option | UA registration | NSZU | Cost orientation | Access pathway |
|---|---|---|---|---|
| Standard plan Paclitaxel + carboplatin (salivary gland carcinoma, palliative) (REG-PACLITAXEL-CARBOPLATIN-SALIVARY) | ✓ registered | ✓ covered | ₴-? — verify pathway | NSZU formulary |
| Trial · NCT06923826 Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC) No UA site listed — international referral required | — unknown | — unknown | self-pay: ₴0/course | Trial sponsor |
| Trial · NCT06047236 Immune Biomarker Study for Salivary Gland Carcinoma No UA site listed — international referral required | — unknown | — unknown | self-pay: ₴0/course | Trial sponsor |
| Trial · NCT04870762 Customized 3D Printed Oral Stents During Head and Neck Radiotherapy No UA site listed — international referral required | — unknown | — unknown | self-pay: ₴0/course | Trial sponsor |
| Trial · NCT04214366 Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation No UA site listed — international referral required | — unknown | — unknown | self-pay: ₴0/course | Trial sponsor |
| Trial · NCT07686575 Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma No UA site listed — international referral required | — unknown | — unknown | self-pay: ₴0/course | Trial sponsor |
| Trial · NCT07072143 An International Study on Pediatric Patients With Rare Tumors. No UA site listed — international referral required | — unknown | — unknown | self-pay: ₴0/course | Trial sponsor |
| Trial · NCT07507578 A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma No UA site listed — international referral required | — unknown | — unknown | self-pay: ₴0/course | Trial sponsor |
| Trial · NCT00898638 Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants No UA site listed — international referral required | — unknown | — unknown | self-pay: ₴0/course | Trial sponsor |
| Trial · NCT06805617 A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers No UA site listed — international referral required | — unknown | — unknown | self-pay: ₴0/course | Trial sponsor |
| Trial · NCT05483374 The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers No UA site listed — international referral required | — unknown | — unknown | self-pay: ₴0/course | Trial sponsor |
Cost information is orientation. Verify with a specific pharmacy / foundation / trial site. Status updated: 2026-08-17.